Text Size

Molecular Analysis Of Bladder Cancer

This study is currently recruiting participants.
Verified June 2011 by Lahey Clinic
Sponsor:
Information provided by:
Lahey Clinic
ClinicalTrials.gov Identifier:
NCT00871754
First received: March 26, 2009
Last updated: June 21, 2011
Last verified: June 2011
History of Changes
  Purpose

This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.


Condition
Bladder Cancer
Bladder Neoplasms

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Molecular Analysis Of Bladder Cancer

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Lahey Clinic:

Biospecimen Retention:   Samples With DNA

Blood


Estimated Enrollment: 5000
Study Start Date: April 1988
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patient's undergoing removal of a malignant bladder tumor

Criteria

Inclusion Criteria:

  • Bladder cancer
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00871754

Contacts
Contact: John A Libertino, M.D. 781-744 ext 2511 John.A.Libertino@Lahey.org
Contact: Linda M Topjian 781-744 ext 8711 Linda.M.Topjian@Lahey.org

Locations
United States, Massachusetts
Lahey Clinic Recruiting
Burlington, Massachusetts, United States, 01805
Contact: John A Libertino, M.D.     781-744-2511     John.A.Libertino@Lahey.org    
Contact: Linda M Topjian, M.D.     781-744-8711     Linda.M.Topjian@Lahey.org    
Sponsors and Collaborators
Lahey Clinic
Investigators
Principal Investigator: John A. Libertino, M.D. Lahey Clinic
  More Information

No publications provided

Responsible Party: John A. Libertino, M.D., Lahey Clinic, Inc.
ClinicalTrials.gov Identifier: NCT00871754     History of Changes
Other Study ID Numbers: 88-009A
Study First Received: March 26, 2009
Last Updated: June 21, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Lahey Clinic:
Bladder Cancer
Cancer, bladder
Urinary Bladder Cancer

Additional relevant MeSH terms:
Urinary Bladder Neoplasms
Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
 Neoplasms by Site
Urinary Bladder Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on May 19, 2013